8 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... #Meningitis #Antibiotics ... #Antimicrobials ... Empiric #Coverage #InfectiousDiseases ... #Pharmacology #
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
therapy in bacterial meningitis ... #IDSA #Meningitis ... #Antibiotics #Antimicrobial ... Pathogens #Isolated #InfectiousDiseases ... #Pharmacology #
Mechanism of antibacterial drug resistance


#pharmacology #antibiotics #comparison #review #mechanismofaction
antibacterial drug ... resistance #pharmacology ... #antibiotics #comparison ... #review #mechanismofaction
Antifungal Polyenes - Amphoterecin B, Abelcet, Ambisome - Antibiotics Class Overview

Mechanism: binds ergosterol in membrane and
Drug of choice for ... , Cryptococcal Meningitis ... voriconazole is drug ... #Pharmacology #Antibiotics ... #Review #Overview
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... pneumonia and meningitis ... - Drug levels ... #Pharmacology #Antibiotics ... #Review #Overview
Vancomycin and Dalbavancin (lipoglycopeptide antibiotics) - Antibiotics Class Overview

Mechanism: Glycopeptide -  inhibits cell wall synthesis
) - Antibiotics ... including bacteremia, meningitis ... Drug of choice for ... #Pharmacology #Antibiotics ... #Review #Overview
CSF Penetration of Antimicrobials

Despite the poor CSF penetration, beta-lactams have the most research documenting successful treatment
Penetration of Antimicrobials ... community-acquired meningitis ... compared to other antibiotic ... #InfectiousDiseases ... #Pharmacology
Chloramphenicol - Antibiotics Class Overview

– 50S ribosomal inhibitor.   IV or PO (but PO form
Chloramphenicol - Antibiotics ... for bacterial meningitis ... several weeks after drug ... #Pharmacology #Antibiotics ... #Review #Overview